Related Experiment Video
Updated: May 23, 2025

Detection of Total Reactive Oxygen Species in Adherent Cells by 2',7'-Dichlorodihydrofluorescein Diacetate Staining
Published on: June 23, 2020
An Oxidative Stress Nanoamplifier with Efficient Non-Fenton-Type Hydroxyl Radical Generation and Sulfur Dioxide
Shasha Zhao1, Zhonghuan Qu1, Likai Wang1
1The Education Ministry Key Lab of Resource Chemistry, Joint International Research Laboratory of Resource Chemistry, Ministry of Education, Shanghai Key Laboratory of Rare Earth Functional Materials, Shanghai Municipal Education Committee Key Laboratory of Molecular Imaging Probes and Sensors, and Shanghai Frontiers Science Center of Biomimetic Catalysis, College of Chemistry and Materials Science, Shanghai Normal University, Shanghai 200234, China.
Abstract:
Overcoming tumor antioxidant defenses remains a critical challenge for reactive-oxygen-species-mediated tumor therapies. To address this problem, herein, a theranostic nanomedicine designated as CCM@MIB has been elaborately constructed. Homologous cancer cell membrane (CCM) camouflage significantly enhances the selective accumulation of the nanomedicine at tumor sites. In response to the tumor microenvironment (TME), CCM@MIB controllably releases Mn ions and sulfur dioxide (SO2) molecules. The released Mn ions catalyze the self-oxidation of isoniazid to generate highly toxic •OH, while the SO2 produced by benzothiazole sulfinate effectively disrupts tumor antioxidant defense systems. The catalase-like activity endowed by Mn ions and the increased intracellular •O2- level induced by SO2 further promote •OH production. Therefore, such an intellectual combination of non-Fenton-type catalytic therapy and SO2 gas therapy significantly amplifies oxidative stress and efficiently suppresses tumor growth. Additionally, the TME-activated magnetic resonance imaging contrast performance of CCM@MIB is beneficial for guiding antitumor treatment. This considerate strategy designed in our work provides an ingenious paradigm for the development of efficient antitumor therapies.

